A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells

Por Tate, C M, Pallini, R, Ricci-Vitiani, L, Dowless, M, Shiyanova, T, D'Alessandris, G Q, Morgante, L, Giannetti, S, Larocca, L M, di Martino, S, Rowlinson, S W, De Maria, R, Stancato, L
Publicado em 2012

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome

Por Marziali, G., Signore, M., Buccarelli, M., Grande, S., Palma, A., Biffoni, M., Rosi, A., D’Alessandris, Q.G., Martini, M., Larocca, L. M., De Maria, R., Pallini, R., Ricci-Vitiani, L.
Publicado no Sci Rep (2016)

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo

Por Signore, M, Pelacchi, F, di Martino, S, Runci, D, Biffoni, M, Giannetti, S, Morgante, L, De Majo, M, Petricoin, E F, Stancato, L, Larocca, L M, De Maria, R, Pallini, R, Ricci-Vitiani, L
Publicado em 2014

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas

Por Ciceroni, C, Bonelli, M, Mastrantoni, E, Niccolini, C, Laurenza, M, Larocca, L M, Pallini, R, Traficante, A, Spinsanti, P, Ricci-Vitiani, L, Arcella, A, De Maria, R, Nicoletti, F, Battaglia, G, Melchiorri, D
Publicado em 2013